trending Market Intelligence /marketintelligence/en/news-insights/trending/weffly7mj548kgh3mwhuiq2 content esgSubNav
In This List

Altimmune CFO resigns; interim replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Altimmune CFO resigns; interim replacement named

Altimmune Inc. said Elizabeth Czerepak resigned as the company's CFO and executive vice president of corporate development.

Czerepak, who also performed the functions of the company's principal accounting officer, left to pursue other opportunities.

The Gaithersburg, Md.-based biotechnology company named Will Brown as acting CFO and principal accounting officer until a replacement is found.

Brown has been engaged by Altimmune as an independent consultant since February.